ANQA Clinician Survey

AI-Powered ADHD Diagnostics: Healthcare Provider Perspectives

ENDE

Estimated time: 10–15 minutes

Incentive: Summary of findings and early demo access

Introduction

We are developing an AI-powered platform to support ADHD diagnosis and would value your professional insights. This research will inform the development of clinician-assistive software designed to enhance, not replace, clinical decision-making.

Auto-restore answersEnable to automatically restore half-finished surveys on this device.
Progress (0/0)0%

Section A

Professional Background

A1. Primary professional role
Other:
A2. Years of clinical experience
A3. Practice setting
Other:
A4. Geographic location
Other:
Other:
A5. Patient population (select all that apply)
A6. Approximate number of ADHD patients you see per month

Section B

Current ADHD Diagnostic Workflow

B1. Diagnostic tools used (select all that apply)
Other:
B2. Average time spent on complete ADHD diagnostic evaluation
B3. Appointments typically required for ADHD diagnosis
B4. Current wait time for new ADHD evaluations
B5. Most significant bottlenecks (select up to 3)
Other:

Section C

Documentation & Reporting

C1. Time spent on documentation per ADHD evaluation
C2. Burden of current diagnostic documentation

1 = No burden, 5 = Excessive burden

C3. Components of an ideal ADHD diagnostic report (select all that apply)
C4. Preferred format for AI-generated diagnostic reports

Section D

Technology Integration

D1. Current Electronic Health Record (EHR) system
Other:
Other:
D2. Importance of EHR integration for new diagnostic tools

1 = Not important, 5 = Essential

D3. Experience with AI/machine learning tools in clinical practice
D4. Preferred method for accessing AI diagnostic tools

Section E

AI-Assisted ADHD Diagnosis

E1. Interest level in AI-powered ADHD diagnostic support tools
E2. Acceptable false positive rate for AI ADHD screening tool
E3. Acceptable false negative rate for AI ADHD screening tool
E4. Most valuable AI capabilities for ADHD diagnosis (select top 3)
E5. Primary concerns about AI-assisted ADHD diagnosis (select all that apply)

Section F

Multimodal Assessment

F1. Value of the following AI assessment modalities (1-5)

1 = Not important, 5 = Essential

Voice/speech pattern analysis

Eye-tracking and gaze patterns

Facial expression analysis

Motor movement patterns

Cognitive performance testing

Conversational pattern analysis

F2. Comfort level with patients providing video/audio data for AI analysis
F3. Patient populations where AI screening might be most beneficial (select all that apply)

Section G

Clinical Decision Support

G1. Preferred presentation of AI diagnostic suggestions
G2. Importance of AI transparency/explainability

1 = Not important, 5 = Essential

G3. Preferred level of AI involvement in diagnosis
G4. Would you use an AI tool that identifies patients who may benefit from ADHD evaluation?

Section H

Implementation & Training

H1. Training requirements for adopting AI diagnostic tools
H2. Factors that would facilitate adoption (select all that apply)
H3. Barriers to implementing AI diagnostic tools (select all that apply)

Section I

Market & Economics

I1. Current reimbursement rate for ADHD evaluation (EUR)
I2. Willingness to pay for an AI ADHD diagnostic tool
I3. Reasonable monthly cost for AI diagnostic platform (EUR)

Section J

Quality & Outcomes

J1. Most important outcome measures for AI diagnostic tools (select top 3)
J2. How would you evaluate the success of an AI ADHD diagnostic tool?
J3. Specific features you would want in an AI ADHD platform?

Section K

Professional Development

K1. Interest in research collaboration with AI diagnostic platform developers
K2. Willingness to participate in clinical validation studies
K3. Interest in early access/beta testing of AI platform

Section L

Final Comments

L1. Additional thoughts on AI in ADHD diagnosis?
L2. What would make you most likely to adopt an AI ADHD diagnostic tool?
L3. Contact information (optional)
Preferred communication:

This survey is conducted by ANQA Digital Health for research and development purposes. All responses will be kept confidential and are used only for product development.